Abstract
The magnetic resonance bone marrow patterns in thalassemia were evaluated to determine changes produced by transfusion and chelation therapy. Thirteen patients had T1-and T2-weighted images of the spine, pelvis and femurs. Three received no therapy (age range 2.5–3 years). Three were “hypertransfused” (transfused to maintain a hemoglobin greater than 10 g/dl) and not chelated because of age (age range 6 months–8 years). Seven were “hypertransfused” and chelated (age range 12–35 years). Signal characteristics of marrow were compared with those of surrounding muscle and fat. Fatty marrow (isointense with subcutaneous fat) was compared with red marrow (hypointense to fat and slightly hyperintense to muscle). Marrow hypointense to muscle was identified as iron deposition within red marrow. The untreated group demonstrated signal consistent with red marrow throughout the central and peripheral skeleton. Hypertransfused but not chelated patients demonstrated marked iron deposition in the central and peripheral skeleton. Hypertransfused and chelated patients demonstrated iron deposition in the central skeleton and a mixed appearance of marrow in the peripheral skeleton. The MR appearance of marrow in thalassemia is a reflection of the patient's transfusion and chelation therapy. Iron deposition occurs despite chelation therapy in sites of active red marrow. As red marrow retreats centrally with age, so does the pattern of iron deposition. The long-term biological effects of this iron deposition are unknown.
Similar content being viewed by others
References
Kaneko K, Humbert JH, Kogutt MS, Robinson AE (1993) Iron deposition in cranial bone marrow with sickle cell disease: MR assessment using a fat suppresion technique. Pediatr Radiol 23: 435–438
Moore SG, Dawson KL (1990) Red and yellow marrow in the femur: age-related changes in appearance at MR imaging. Radiology 175: 219–223
Jaramillo D, Laor T, Hoffer FA, et al (1991) Epiphyseal marrow in infancy: MR imaging. Radiology 180: 809–812
Hartkamp MJ, Babyn PS, Oliveri NF (1993) Spinal deformities in deferoxamine-treated homozygous beta-thalassemia major patients. Pediatr Radiol 23: 525–528
Cooley TB, Witwer ER, Leep P (1927) Anemia in children with splenomegaly and peculiar changes in the bones; report of cases. Am J Dis Child 34: 347–363
Nathan DA, Osler FA (1993) Hematology of infancy and childhood, 4th edn. Saunders, Philadelphia, pp 783–880
Caffey J (1937) The skeletal changes in the chronic hemolytic anemias (erythoblastic anemia, sickle cell anemia and chronic hemolytic icterus). AJR 37: 293–324
Caffey J (1957) Cooley's anemia: a review of the roentgenographic findings in the skeleton. AJR 78: 381–391
Ellis JT, Shulman I, Smith CH (1954) Generalized siderosis with fibrosis of liver and pancreas in Cooley's (Mediterranean) anemia with observations on the pathogenesis of the siderosis and fibrosis. Am J Pathol 30: 287–303
Brasch RC, Wesbey GE, Gooding CA, Koerper MA (1984) Magnetic resonance imaging of transfusional hemosiderosis complicating thalassemia major. Radiology 150: 767–771
Kricum ME (1985) Red-yellow marrow conversion: its effect on the location of some solitary bone lesions. Skeletal Radiol 14: 10–19
Piomelli S, Loew T (1991) Management of thalassemia major (Cooley's anemia). Hematol Oncol Clin North Am 5: 557–569
Siegelman ES, Outwater E, Hanau CA, et al (1994) Abdominal iron distribution in sickle cell disease: MR findings in transfusion and nontransfusion-dependent patients. J Comput Assist Tomogr 18: 63–67
Oliveri NF, Koren G, harns J, et al (1992) Growth failure and bony changes induced by deferoxamine. Am J Pediatr Hematol Oncol 14: 48–56
Miller TT, Caldwell G, Kaye JJ, Arken S, Burke S, Brill PW (1993) MR imaging of deferoxamine-induced bone dysplasia in an 8-year-old female with thalassemia major. Pediatr Radiol 23: 523–524
Brill PW, Winchester P, Giardina PJ, Cunningham-Rundles S (1991) Deferoxamine-induced bone dysplasia in patients with thalassemia major. AJR 156: 561–565
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levin, T.L., Sheth, S.S., Ruzal-Shapiro, C. et al. MRI marrow observations in thalassemia: The effects of the primary disease, transfusional therapy, and chelation. Pediatr Radiol 25, 607–613 (1995). https://doi.org/10.1007/BF02011827
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02011827